Substance / Medication

Finafloxacin

Overview

Active Ingredient
finafloxacin
RxNorm CUI
1598641

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Pharmacokinetics of Intravenous Finafloxacin in Healthy Volunteers.
Taubert Max, Chiesa Joseph, Lückermann Mark et al. · Antimicrob Agents Chemother · 2017
PMID: 28784673RCTFull text (PMC)
Human pharmacokinetics and safety profile of finafloxacin, a new fluoroquinolone antibiotic, in healthy volunteers.
Patel Heena, Andresen Arne, Vente Andreas et al. · Antimicrob Agents Chemother · 2011
PMID: 21709093RCTFull text (PMC)
Early Clinical Assessment of the Antimicrobial Activity of Finafloxacin Compared to Ciprofloxacin in Subsets of Microbiologically Characterized Isolates.
Vente Andreas, Bentley Christine, Lückermann Mark et al. · Antimicrob Agents Chemother · 2018
PMID: 29339393TrialFull text (PMC)
Urinary pharmacokinetics and bactericidal activity of finafloxacin (200 and 800 mg) in healthy volunteers receiving a single oral dose.
Wagenlehner Florian M E, Wagenlehner Christine M, Blenk Birgit et al. · Chemotherapy · 2011
PMID: 21358200Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Finafloxacin (substance)
SNOMED CT
708794002
UMLS CUI
C2825286
RxNorm CUI
1598641

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.